Kiniksa Reports First Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
- ARCALYST® (rilonacept) launched as the first and only FDA-approved therapy for recurrent pericarditis -- Mavrilimumab Phase 2 severe COVID-19...
Staff
Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21 Two-Day Live Virtual Educational Symposium
Panel Discussion and Presentation part of Future of Cell and Gene Therapies EventBOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Ziopharm...
Treatment’s healthcare AI developed by over 40 doctors
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (CSE: TRUE), a disruptive healthcare technology company that...
Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Boosting Regimen Study
Study will evaluate safety and immunogenicity of multiple distinct dosing regimens of norovirus oral vaccine candidate Norovirus infects 15% of...
Palisade Bio Hosting Key Opinion Leader Webinar on LB1148, an Oral Serine Protease Inhibitor for Postoperative GI Dysfunction
Webinar on Thursday, May 13th @ 1pm ETCARLSBAD, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI),...
Recce Pharmaceuticals Announces Positive Data on Bactericidal Activity of RECCE® 327 Against All Six ESKAPE Pathogens
ESKAPE Pathogens: Standardised and Drug Resistant Broad Efficacious Dosing Range Figure 1 Minimum inhibitory concentration (ppm) of RECCE® 327 against...
Neoleukin Therapeutics to Participate in BofA Securities 2021 Healthcare Conference
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Rezolute Announces Positive RZ402 Study Results Demonstrating Potential for Once Daily Dosing of an Oral Plasma Kallikrein Inhibitor for Diabetic Macular Edema
Results allow the Company to advance development, including planning for its multiple-ascending dose clinical studyREDWOOD CITY, Calif., May 04, 2021...
Pennant Announces First Quarter 2021 Earnings Release and Call
EAGLE, Idaho, May 04, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries...
Intra-Cellular Therapies to Host First Quarter 2021 Financial Results Conference Call and Webcast
NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Abpro Announces Presentation and Data at the 2021 Annual Association for Research in Vision and Ophthalmology of ABP201 for the Treatment of Wet Age-related Macular Degeneration
Data showed reduction of neovascular lesion formation and vascular leakage in a rodent model of choroidal neovascularizationABP201 performed equally or...
Yumanity Therapeutics to Host Virtual R&D Day on Monday, May 17, 2021
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a biopharmaceutical company focused on the development of innovative,...
VistaGen Therapeutics Announces Appointment of Ann Cunningham as Chief Commercial Officer
Ann Cunningham has a proven pharmaceutical commercial track record of more than 25 years delivering sales, marketing, and global life...
LifeMD to Release First Quarter 2021 Financial Results on Thursday, May 13, 2021
Hosted conference call to begin at 4:30 p.m. ETNEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”)...
Mereo BioPharma to Hold Virtual R&D Day on Thursday, May 13, 2021
LONDON and REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or “the...
Solid Biosciences Highlights Expertise in AAV Gene Therapy with Multiple Abstracts to be Presented at the American Society of Gene & Cell Therapy 24th Annual Meeting
-Data from studies of novel AAV vectors and AAV immunology and an encore of 12-month safety, efficacy and patient-reported outcomes...
Oculis Announces an Oversubscribed US$57 million Series C Financing
New leading international life science investors join current institutional investors with proceeds to: Advance novel, late-stage Investigational ophthalmology drugs OCS-01...
Soleno Therapeutics Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome
Results Show Improvement in Multiple Behavioral Domains Following Treatment with DCCR Data Presented in a Poster at the Pediatric Academic...
Scipher Applies Spectra™ Platform to Discover Drugs Targeting Autoimmune Patients Refractory to Existing Therapies
- Leverages large genomic database from Scipher’s testing business.- Proven Spectra™ platform brings precision therapeutics to autoimmune diseases.- Program commercialized through...
electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache
ROCKAWAY, NJ, May 04, 2021 (GLOBE NEWSWIRE) -- -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the...